California Public Employees Retirement System decreased its position in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 4.8% in the second quarter, Holdings Channel reports. The fund owned 861,337 shares of the company’s stock after selling 43,748 shares during the period. California Public Employees Retirement System’s holdings in Henry Schein were worth $69,854,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently bought and sold shares of HSIC. Cambridge Investment Research Advisors Inc. lifted its position in Henry Schein by 2.4% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 5,262 shares of the company’s stock worth $459,000 after acquiring an additional 122 shares during the last quarter. HighTower Advisors LLC lifted its position in Henry Schein by 18.9% during the 1st quarter. HighTower Advisors LLC now owns 14,030 shares of the company’s stock worth $1,220,000 after acquiring an additional 2,226 shares during the last quarter. MetLife Investment Management LLC raised its position in shares of Henry Schein by 23.2% during the first quarter. MetLife Investment Management LLC now owns 37,733 shares of the company’s stock valued at $3,290,000 after buying an additional 7,095 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in shares of Henry Schein by 6.6% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 18,555 shares of the company’s stock valued at $1,618,000 after buying an additional 1,149 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in shares of Henry Schein by 4.1% during the first quarter. Dimensional Fund Advisors LP now owns 1,300,357 shares of the company’s stock valued at $113,386,000 after buying an additional 51,106 shares during the last quarter. Institutional investors and hedge funds own 93.31% of the company’s stock.
Henry Schein Price Performance
Shares of Henry Schein stock opened at $68.90 on Wednesday. The company has a current ratio of 1.72, a quick ratio of 0.91 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $9.00 billion, a price-to-earnings ratio of 20.51, a P/E/G ratio of 1.87 and a beta of 0.87. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $89.72. The firm’s 50-day moving average price is $70.52 and its two-hundred day moving average price is $75.19.
Analyst Ratings Changes
A number of research analysts have recently commented on HSIC shares. Barrington Research cut their price objective on shares of Henry Schein from $90.00 to $82.00 and set an “outperform” rating for the company in a research report on Tuesday. UBS Group cut their price objective on shares of Henry Schein from $82.00 to $75.00 and set a “neutral” rating for the company in a research report on Tuesday. Morgan Stanley cut their price objective on shares of Henry Schein from $69.00 to $65.00 and set an “underweight” rating for the company in a research report on Tuesday. Credit Suisse Group reaffirmed an “outperform” rating and set a $96.00 price objective on shares of Henry Schein in a research report on Tuesday, August 8th. Finally, Piper Sandler cut their price objective on shares of Henry Schein from $94.00 to $84.00 and set an “overweight” rating for the company in a research report on Thursday, October 26th. One analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the company. According to data from MarketBeat, Henry Schein has a consensus rating of “Hold” and a consensus target price of $78.75.
Read Our Latest Analysis on Henry Schein
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
See Also
- Five stocks we like better than Henry Schein
- The 3 Best Blue-Chip Stocks to Buy Now
- Analyst says Archer Aviation may double. Is it time to buy?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Alibaba’s bottom is in: Analysts see a monster rally ahead
- How to Invest in Solar Energy
- TripAdvisor is on AI-powered recovery from record lows
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.